Literature DB >> 3572752

Quantitation of the release of doxorubicin from colloidal dosage forms using dynamic dialysis.

P K Gupta, C T Hung, D G Perrier.   

Abstract

The release of doxorubicin from submicrometer bovine serum albumin (BSA) microspheres has been quantitated using dynamic dialysis. Mathematical models have been proposed based on zero- or first-order release of drug from solid colloidal matrices. The models also account for the permeability constant of the dialysis membrane. Results obtained by the dynamic dialysis technique resemble those obtained using a conventional dissolution method. The release of doxorubicin from the microspheres can be adequately described by a biphasic zero-order model.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3572752     DOI: 10.1002/jps.2600760211

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

1.  Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability.

Authors:  Shun Han; Jin-qiu Shen; Yong Gan; Hai-ming Geng; Xin-xin Zhang; Chun-liu Zhu; Li Gan
Journal:  Acta Pharmacol Sin       Date:  2010-08       Impact factor: 6.150

2.  Release, partitioning, and conjugation stability of doxorubicin in polymer micelles determined by mechanistic modeling.

Authors:  Andrei Ponta; Kyle D Fugit; Bradley D Anderson; Younsoo Bae
Journal:  Pharm Res       Date:  2014-11-19       Impact factor: 4.200

3.  A novel in vitro release method for submicron sized dispersed systems.

Authors:  N Chidambaram; D J Burgess
Journal:  AAPS PharmSci       Date:  1999

4.  Design of new formulations for topical ocular administration: polymeric nanocapsules containing metipranolol.

Authors:  C Losa; L Marchal-Heussler; F Orallo; J L Vila Jato; M J Alonso
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

5.  Experiments and modeling of controlled release behavior of commercial and model polymer-drug formulations using dialysis membrane method.

Authors:  Alok Ranjan; Prateek K Jha
Journal:  Drug Deliv Transl Res       Date:  2020-04       Impact factor: 4.617

6.  Theranostic combinatorial drug-loaded coated cubosomes for enhanced targeting and efficacy against cancer cells.

Authors:  Leilei Zhang; Jinlong Li; Dan Tian; Lihua Sun; Xu Wang; Miao Tian
Journal:  Cell Death Dis       Date:  2020-01-02       Impact factor: 8.469

7.  Possible contribution of sialic acid to the enhanced tumor targeting efficiency of nanoparticles engineered with doxorubicin.

Authors:  Song Yi Lee; Suyeong Nam; Ja Seong Koo; Sungyun Kim; Mingyu Yang; Da In Jeong; ChaeRim Hwang; JiHye Park; Hyun-Jong Cho
Journal:  Sci Rep       Date:  2020-11-12       Impact factor: 4.379

8.  A polytherapy based approach to combat antimicrobial resistance using cubosomes.

Authors:  Xiangfeng Lai; Mei-Ling Han; Yue Ding; Seong Hoong Chow; Anton P Le Brun; Chun-Ming Wu; Phillip J Bergen; Jhih-Hang Jiang; Hsien-Yi Hsu; Benjamin W Muir; Jacinta White; Jiangning Song; Jian Li; Hsin-Hui Shen
Journal:  Nat Commun       Date:  2022-01-17       Impact factor: 14.919

9.  In vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting.

Authors:  Mohamed Nasr; Mohamed K Ghorab; Ahmed Abdelazem
Journal:  Acta Pharm Sin B       Date:  2014-12-29       Impact factor: 11.413

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.